Organon & Co Patents – Key Insights and Stats

Organon & Co has a total of 2674 patents globally, out of which 1303 have been granted. Of these 2674 patents, more than 24% patents are active. Europe is where Organon & Co has filed the maximum number of patents, followed by USA and Mexico. Parallelly, Europe seems to be the main focused R&D center and USA is the origin country of Organon & Co.

Organon & Co was founded in 2020 and its predecessor is Organon International founded in 1923. Organon & Co operates as a pharmaceutical company. The Company develops and produces medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies, and asthma. Organon & Co serves customers worldwide. As of March 2022, Organon & Co has a market cap of $8.20 Billion.

Do read about some of the most popular patents of Organon & Co which have been covered by us in this article and also you can find Organon & Co patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Organon & Co patent portfolio.

How many patents does the CEO of Organon & Co have?

The CEO, Kevin Ali have 0 patents.

How many patents does Organon & Co have?

Organon & Co has a total of 2674 patents globally. These patents belong to 577 unique patent families. Out of 2674 patents, 656 patents are active.

How many Organon & Co patents are Alive/Dead?

Worldwide Patents

Organon & Co Patents Portfolio

Patent Families

Organon & Co Patents

How Many Patents did Organon & Co File Every Year?

Organon & Co Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantOrganon & Co Applications FiledOrganon & Co Patents Granted
201130100
2012631
2013324
2014123
20157
20164
201711
201812
2019121
20203
202122
20221

Which Organon & Co Drug Patents are Expiring in the Next 10 Years?

The patent no. US7612058B2 which is expiring in Oct, 2025, describing the formulas for treating vascular conditions, diabetes, and obesity, while reducing sterol levels. They contain a peroxisome proliferator-activated receptor activator and a sterol absorption inhibitor like substituted azetidinone or substituted -lactam.

Given below is the list of few drugs patented by Organon & Co accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.

Drug NamePatent NumberPatent TitlePatent Expiration
ZetiaUS7612058B2Methods For Inhibiting Sterol AbsorptionOct, 2025
ImplanonUS8722037B2X-Ray Visible Drug Delivery DeviceSep, 2027

How Many Patents did Organon & Co File in Different Countries?

Organon & Co Worldwide Patents

Countries in which Organon & Co Filed Patents

CountryPatents
Europe186
United States Of America154
Mexico98
Austria96
Korea (South)92
Brazil91
Argentina82
Australia81
Spain80
Chile79
Hong Kong (S.A.R.)79
Denmark77
India76
Taiwan72
Singapore72
Japan72
New Zealand66
Russian Federation66
Norway64
Poland63
China62
Germany60
Peru58
South Africa57
Canada57
Indonesia41
Portugal41
Viet Nam36
Croatia35
Philippines35
Cyprus32
Ukraine31
Ecuador30
Malaysia26
Slovenia24
Colombia19
Serbia18
Czech Republic18
Hungary13
Slovakia13
United Kingdom11
Turkey8
Finland8
Israel6
Iceland6
Latvia4
Uruguay3
United Arab Emirates2
Luxembourg2
Saudi Arabia1
Egypt1
Netherlands1
Honduras1
Lithuania1
Macao1
Montenegro1
Tunisia1
Costa Rica1
El Salvador1
Romania1
Dominican Republic1

Where are Research Centers of Organon & Co Patents Located?

Research Centers of Organon & Co Patents

10 Best Organon & Co Patents

WO2008156712A1 is the most popular patent in the Organon & Co portfolio. It has received 964 citations so far from companies like Merck Sharp & Dohme Corp, Millennium Pharmaceuticals and GlaxoSmithKline.

Below is the list of 10 most cited patents of Organon & Co:

Publication NumberCitation Count
WO2008156712A1964
WO2011014438A1109
WO2006095014A199
WO2007065916A195
WO2010136438A179
WO2008020081A167
WO2008033764A266
WO2006027347A166
US20050287203A159
WO2007039563A155

Patents acquired by Organon & Co

Organon & Co has acquired 30 patents from other companies which is not associated with Organon & Co.

Below the table shows the patent acquisition of Organon & Co –

CompanyPatents Families
AkzoNobel24
Avecia Limited1
Diosynth Rtp Inc1
Forbes Medi-Tech Inc1
Kanebo Ltd1
Merck Sharp & Dohme1
Zeneca Limited1

EXCLUSIVE INSIGHTS COMING SOON!

What are Organon & Cos key innovation segments?

What Technologies are Covered by Organon & Co?

The chart below distributes patents filed by Organon & Co in different countries on the basis of the technology protected in patents. It also represents the markets where Organon & Co thinks it’s important to protect particular technology inventions.

R&D Focus: How Organon & Co search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Organon & Co?

Related Articles

Aizant Patents – Insights & Stats (Updated 2024)

Aizant has a total of 64 patents globally, out of which 8 have been granted. Of these 64 patents, more than 45% patents are active. India is where Aizant has filed the maximum number of patents, followed by United States of America and Canada. Parallelly, India seems to be the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.